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Abstract
Autophagy assures cellular homeostasis, and
gains increasing importance in cancer, where it
impacts on carcinogenesis, propagation of the
malignant phenotype and development of resist-
ance. To date, its tissue-based analysis by
immunohistochemistry remains poorly standard-
ized. Here we show the feasibility of specifically
and reliably assessing the autophagy markers
LC3B and p62 (SQSTM1) in formalin fixed and
paraffin embedded human tissue by immunohis-
tochemistry. Preceding functional experiments
consisted of depleting LC3B and p62 in H1299
lung cancer cells with subsequent induction of
autophagy. Western blot and immunofluores-
cence validated antibody specificity, knockdown
efficiency and autophagy induction prior to fixa-
tion in formalin and embedding in paraffin. LC3B
and p62 antibodies were validated on formalin
fixed and paraffin embedded cell pellets of treated
and control cells and finally applied on a tissue
microarray with 80 human malignant and non-
neoplastic lung and stomach formalin fixed and
paraffin embedded tissue samples. Dot-like stain-
ing of various degrees was observed in cell pellets
and 18/40 (LC3B) and 22/40 (p62) tumors,
respectively. Seventeen tumors were double posi-
tive for LC3B and p62. P62 displayed additional
significant cytoplasmic and nuclear staining of
unknown significance. Interobserver-agreement
for grading of staining intensities and patterns
was substantial to excellent (kappa values 0.60 -
0.83). In summary, we present a specific and reli-
able IHC staining of LC3B and p62 on formalin
fixed and paraffin embedded human tissue. Our
presented protocol is designed to aid reliable
investigation of dysregulated autophagy in solid
tumors and may be used on large tissue collec-
tives.
Introduction
Under stress conditions such as nutrient-
shortage cells activate an alternative source of
energy that enables continuous cell survival.1,2
This process is known as macroautophagy (here-
after referred to as autophagy) and allows recy-
cling of long-lived proteins and organelles to
maintain cellular homeostasis.3,4 A hallmark of
autophagy is the formation of double-membrane
cytosolic vacuoles, the so-called autophagosomes,
in which proteins and organelles are engulfed.
Later, the autophagosomes fuse with lysosomes
to degrade and recycle their content. The process
of autophagy is regulated by a series of
autophagy-related genes (ATGs).5 Two ubiquitin-
like conjugation systems are crucial for
autophagosome formation and cargo recruit-
ment, namely the ATG12-ATG5-ATG16 and the
ATG8 conjugation system.6 The latter one is medi-
ating the lipidation of ATG8 family members
including the human homologoues LC3A-C and
GABARAPs.7 LC3B is the most widely used marker
to monitor autophagy.8,9 Lipidated LC3B (LC3B-II)
is incorporated into the outer and inner
autophagosomal membrane9 and thereby allows
for detection of different stages of autophagic
vesicles. An increasing number of studies found
that autophagy can be highly selective. Selectivity
is achieved by autophagy receptors that on the
one hand are able to recognize ligand bound
cargo and on the other hand interact with the
autophagy machinery.10 One of the best-studied
autophagy receptors is p62, also known as
sequestosome1 (SQSTM1), which is involved in
autophagy-dependent elimination of many differ-
ent cargos including ubiqutinated protein aggre-
gates and bacteria. Because of its interaction
with LC3, p62 is constantly degraded via
autophagy and autophagy inhibition leads to the
accumulation of p62 positive aggregates.11 Based
on these properties monitoring degradation of
p62 is used to measure autophagic flux under cer-
tain conditions.8 At a physiological level and due
to its homeostatic function, autophagy is impli-
cated in several diseases as e.g. neurodegenera-
tion.12-14 In the context of cancer, autophagy is
seen as a double-edged sword. Under normal con-
ditions autophagy is tumor-suppressive due to its
role in removal of damaged organelles and toxic
protein aggregates. In this function autophagy
prevents genome instability.15 In cancer cells,
however, autophagy may promote tumorigenesis
and resistance to therapy due to its pro-survival
role under stress conditions.16 In the last years,
knowledge about the functional regulation of
autophagy has greatly increased. Unfortunately,
investigation of autophagy in mammalian tissue
apt to deliver additional information about the
role of autophagy and its deregulation in dis-
eases, is still hampered by lack of suitable and
standardized methodology.8 A seminal study on
the immunohistochemical analysis of autophagy
in murine tissue of a conditional Atg7 knock-out
mouse model by Martinet et al. concluded that
LC3 expression is too low for reliable detection
and that p62 also accumulated in autophagy-defi-
cient liver tissue.17 Detection of autophagosomes
by electron microscopy is still regarded as the gold
standard to detect autophagy in tissue. Yet, this
method is time and cost consuming and restrict-
ed to the application on non-formalin fixed and
paraffin embedded (non-FFPE) tissue for best
results.17,18 In contrast, most pathology archives -
where human tissue would be available for dis-
ease specific studies - offer only FFPE tissue.
Since immunohistochemistry (IHC) can be easily
applied on FFPE tissue, a robust and reliable
immunostaining technique for measuring
autophagy would be a valuable tool for the inves-
tigation of this highly important cellular mecha-
nism. Thus, we were aiming at establishing a reli-
able method for detecting autophagy markers in
human tissue sections, particularly in tissue
microarrays. Although several antibodies against
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these proteins are available, which are now wide-
ly used for analysing human tissue, there is still
ample discussion about the reliability of the
immunoreactions, the specificity of the antibod-
ies, and finally the correct interpretation of the
staining results. Therefore, the aim of this work
was to develop a robust and specific IHC staining
protocol for the detection of LC3B and p62 in
human FFPE tissue with special emphasis on its
specificity for autophagy and the interpretation
and the possibility of categorization of the stain-
ing results.
Materials and MethodsPatient tissue samplesCell lines, culture and treatmentconditions
The human non-small cell lung cancer cell
line H1299 was directly obtained from Leibniz-
Institute DSMZ-German collection of
Microorganisms and Cell Cultures and cul-
tured in RPMI-1640 (Sigma-Aldrich, Buchs,
Switzerland) supplemented with 10% FBS
(Sigma-Aldrich, product number: F7524, Lot
number: 012M3396) and antibiotics. For star-
vation experiments cells were seeded and the
next day washed with PBS before the addition
of EBSS (#E2888, Sigma-Aldrich). Cells were
starved for 6 h and Bafilomycin A1 (BML-
CM110, Enzo-Life Sciences, Lausen,
Switzerland) was added for the last two hours
at a final concentration of 200 nM.Generation of knockdown cell lines
H1299 cells were transduced with several
lentiviral vectors (pLKO.1) each of them
expressing a small hairpin (sh)RNA targeting
the LC3B or p62 mRNA (LC3B: NM_022818.2-
247s1c1NM and 022818.2-292s1c1; p62:
NM_003900.2-967s1c1, NM_003900.2-
788s1c1, Sigma-Aldrich) at different regions.
Lentivirus production was performed as
described previously.19 We used the SHC002
control lentiviral vector (Sigma-Aldrich) as a
non-targeting control. Two days after trans-
duction, cells were selected with 1.5 g/mL
puromycin (Sigma-Aldrich) for 2 days before
lowering puromycin concentration to 0.5 g/mL
for another 5 days. Primary antibodies 
Anti-LC3B antibodies were purchased from
Cell Signaling (rabbit monoclonal, clone D11,
#3686, Lausen, Switzerland) and Novus
Biologicals (rabbit polyclonal, #NB600-1384,
LuBioScience, Luzern, Switzerland). The
p62/SQSTM1 antibodies were obtained from
Sigma (mouse monoclonal, clone 2C11,
#WH0008878M1, Leiden, The Netherlands)
and MBL (rabbit polyclonal, #PM0045,
LabForce, Nunningen, Switzerland). Anti-
GAPDH was purchased from Millipore
(MAB374; Millipore, Zug, Switzerland). Western blotting
Cells were washed in PBS before lysis in
urea buffer (8 M urea, 0.5% tritonX) contain-
ing protease inhibitor (complete midi, Roche
Diagnostics, Rotkreuz, Switzerland). After
sonication samples were centrifuged at 14,000
rcf and the supernatant was transferred to a
new tube. Protein concentration was deter-
mined using the Bradford protein assay
(BioRad, Cressier, Switzerland). Thirty µg of
total protein were denatured in Laemmle
buffer at 95°C for 5 min (BioRad), loaded on a
4-20% pre-cast gel (BioRad) and transferred
onto a PVDF membrane using the Trans-
Blot® Turbo™ Transfer system (BioRad). For
p62, GAPDH and LC3B membranes were
blocked during 1 h at room temperature (RT)
using 5% milk, before incubation with the
respective antibody. p62 and LC3B were dilut-
ed 1:1000 whereas GAPDH was diluted 1:5000.
Membranes were incubated o/n at 4°C.
Secondary antibodies were DyLight®650 con-
jugated goat anti-rabbit or DyLight®550 conju-
gated goat anti-mouse (LabForce, Muttenz,
Switzerland). Secondary antibodies were
diluted 1:1000 in 5% milk and incubated 3 h at
RT. Data was acquired using the ChemiDoc™
MP system (BioRad).Immunofluorescence
Cells were seeded onto cover-slides the day
before starting experiments. After treatment as
described above, cells were washed in PBS, pre-
fixed in 4% paraformaldehyde for 15 seconds,
fixed and permeabilized in ice-cold 100%
methanol for 10 min at -20°C. Slides were air
dried and washed with PBS before incubation
for 1 h at RT with the primary antibodies (anti-
LC3B/Cell Signaling 1:200 and anti-p62/Sigma
1:200 in PBS/1%BSA/0.1% Tween). Slides were
washed twice with PBS 0.1% Tween and once
with PBS and incubated for 1 h at RT with the
respective secondary antibodies which were
either FITC conjugated anti-rabbit and Cy3-con-
jugated anti-mouse (#115-166-003, Jackson
Immunore search, Suffolk, UK). Secondary anti-
bodies were diluted 1:130 in PBS/1% BSA/0.1%
Tween.  Images were taken on a confocal micro-
scope Olympus FluoView1000 at 63x objective
magnification. The number of LC3B and p62
positive dots was quantified using ImageJ soft-
ware (1.64r; NIH, Bethesda, MD, USA). To count
the dots a modified version of the plugin was
used as already described.20Embedding of cells for immunohis-tochemical staining
Cells were washed in PBS and pelleted by
centrifugation. Three-four drops of plasma
(Blood Transfusion Service, Bern,
Switzerland) were added to the cells and coag-
ulation was initiated by addition of 1-2 drops
of thrombin (Diagnotec, Liestal, Switzerland).
After incubation for 2 min the pellet was
transferred into an embedding cassette.
Samples were fixed in 4% paraformaldehyde
overnight at RT before they were embedded in
paraffin in the routine pathology laboratory.Tissue microarray 
Selected FFPE tissue of 20 non-small cell
lung carcinomas and 20 gastric adenocarcino-
mas including corresponding non-neoplastic
tissue was retrieved from the archive of the
Institute of Pathology, University of Bern.
Cases were randomly chosen according to
abundant tissue availability. A tissue microar-
ray (TMA) was constructed as previously
described.21 Two punches were transferred to
the TMA acceptor block from each pellet (0.6
mm punches) or tissue (1 mm punches),
respectively.Immunohistochemical staining
The TMA was sectioned at 4 µm. After de-
paraffination, rehydration, and antigen
retrieval, immunohistochemical staining was
performed using an automated immunostain-
er (Bond RX, Leica Biosystems, Heerbrugg,
Switzerland) as follows: LC3B/Cell Signaling
dilution 1:6000 for cell pellets and 1:3000 for
tissue, tris buffer 95°C for 30 min, LC3/Novus
dilution 1:6000 for cell pellets and 1:3000 for
tissue, tris buffer 95°C for 30 min, p62/
SQSTM1/MBL dilution 1:12000 for cell pellets
and 1:8000 for tissue, citrate buffer 100°C for
30 min and p62/SQSTM1/Sigma dilution
1:40000 for both cell pellets and tissue, tris
buffer 95°C for 30 min. Visualization was per-
formed using the Bond Polymer Refine
Detection kit (Leica Biosystems) as instructed
by the manufacturer.Statistical analysis
The SPSS 21 software (SPSS Inc, Chicago,
IL, USA) was used for descriptive and compar-
ative statistical analysis. Associations
between staining patterns were evaluated
using simple cross tabs (c²-test and Fisher’s
exact test). Interobserver agreement was
determined by using kappa values. The signif-
icance level was set at 0.05.
ResultsSpecific LC3B and p62 staining inFFPE cell pellets
Several LC3 antibodies show cross-reactivi-
ty between LC3A or B isoforms, and we decided
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to use a highly specific LC3B antibody (Anti-
LC3B, rabbit monoclonal, clone D11) and a
cross-reactive LC3A/B antibody (rabbit poly-
clonal, #NB600-1384) for comparison.17,22 In
order to test the specificity of the LC3B anti-
bodies, H1299 lung cancer cells were trans-
duced with lentiviral plasmids encoding
shRNAs to target LC3B mRNA. Control and
H1299 LC3B knockdown (shLC3B) cells were
subjected to starvation and Bafilomycin A1 was
added to assess autophagic flux.8 Knockdown
efficiency and autophagy induction were deter-
mined by western blot analysis (Figure 1A).
LC3B-II levels markedly increased in control
cells upon starvation and were further
enhanced after addition of Bafilomycin A1,
indicating activated autophagic flux in the
control cells (Figure 1A, left panel). In compar-
ison, LC3B levels were significantly decreased
in H1299 LC3B knockdown cells (Figure 1A,
right panel). In line with the LC3B western blot
data we found a significant increase in the
number of LC3B positive dots under starvation
as assessed by immunofluorescence
microscopy. The number of LC3B dots further
increased when blocking lysosome acidifica-
tion with Bafilomycin A1, suggesting
enhanced autophagic flux (Figure 1 B,C).
H1299 LC3B depleted cells (Figure 1C, lower
panel) displayed significantly fewer dots under
control as well as starvation conditions. In
agreement with the results of the immunoflu-
orescence and western blot analysis, IHC
staining of FFPE control cells showed a weak
cytoplasmic but also a distinct and differentiat-
ed punctuated staining with starved cells dis-
playing an increased number of LC3B positive
dots with both antibodies used. LC3B depleted
cells showed only a very weak staining with
slightly stronger staining when using the
cross-reactive LC3 antibody, reinforcing the
specificity of the antibody on FFPE tissue
(Figure 1C, right panel). 
p62 knockdown efficiency was lower than
for LC3B as appreciated by western blot analy-
sis, immunocyto- and immunohistochemistry
(Figure 2 A,B). In agreement with the notion
that p62 is degraded via autophagy,  total p62
levels slightly decreased under starvation and
increased over basal levels when flux was
blocked with Bafilomycin A1 (Figure 2A). In
line with these results, immunofluorescence
showed an increase of p62 positive aggregates
in starved cells treated with Bafilomycin A1
(Figure 2B and C, left panel). Accumulation of
p62 under Bafilomycin A1 treatment was also
found in p62 knockdown cells, but to a lesser
extent as shown by quantification of p62 dots
(Figure 2B) and western blot analysis (Figure
2A). As with LC3B knockdown cells, H1299 p62
depleted cells were fixed and embedded in
paraffin and stained for p62 using IHC. IHC
staining applying two different p62 antibodies
clearly showed an increase in p62 dot forma-
tion only in SHC002 control cells upon starva-
tion and Bafilomycin A1 treatment and not in
H1299 p62 knockdown cells (Figure 2C, right
panel). Application of LC3B and p62 staining on FFPE tissue
We applied our findings from FFPE cancer
cell pellets to FFPE human tissue. Strong and
partly dot-like LC3B staining was observed in
peripheral nerves, perivascular smooth muscle
cells and macrophages (Figure 3 A-C, G-I).
Gastric zymogen granules stained faintly posi-
tive for LC3B/Cell Signaling and p62/MBL
(Figure 3E). Nuclear p62 staining was present
in the foveolar mucous neck cells, and extend-
ed towards the surface, particularly in samples
hosting inflammation (Figure 3 D-F). In lung,
type II pneumocytes stained strongly for p62
(Figure 3C). Unequivocal LC3B staining was
not present. All 5 cases of captured bronchial
epithelium showed weak cytoplasmic staining
and dot-like staining for LC3B and p62 in 5 to
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Figure 1. Validation of immunohistochemical staining for LC3B. Autophagy was induced
by starvation in EBSS media, and autophagic flux blocked using the late autophagy
inhibitor Bafilomycin A1. A) LC3B Western blot analysis of H1299 LC3B knockdown
(shLC3B) and control (shCTRL) cells upon starvation and autophagy inhibition;
GAPDH protein expression is shown as a loading control; band quantification was done
using ImageJ software. B) Quantification of LC3B positive dots from immunofluorescent
staining as depicted in C; quantification was performed using ImageJ software; the non-
parametric Mann-Whitney-U was used to compare different groups: *p<0.05. C)
Immunofluorescent staining (left panel) and immunohistochemistry (right panel) of
LC3B in H1299 control and LC3B depleted cells treated as described above; for
immunofluorescence analysis the LC3B/Cell Signaling antibody was used, and nuclei
were counterstained using DAPI; for immunohistochemical staining two different LC3B
antibodies (Cell Signaling and Novus) were applied. Scale bars: 20 µm.
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50% of cells (Figure 3 B-C). In both lung and
gastric carcinomas, we found varying dot-like
staining ranging from absent or only very few
dots to abundant, partly aggregate like dots in
most of the cells (Figure 3 J-M). Faint back-
ground cytoplasmic staining was observed in
15 cases (25%) for LC3B, which was negligible
for further analysis. In contrast, p62 showed
cytoplasmic staining in all cases at various
degrees and nuclear staining in half of the
cases. Unambiguous evaluation of p62 dot-like
staining was hindered in some cases by addi-
tional strong cytoplasmic staining.
According to our observations we divided the
dot like staining patterns into an intensity score
from 0-3 for quantitative evaluation as follows:
score 0, no dots or barely visible dots in <5% of
the cells; score 1, detectable dots in 5-25% of
cells; score 2, readily detectable dots in 25-75%
of cells; score 3, dots in >75% of cells. Diffuse
cytoplasmic staining was assessed as absent or
presenting only faint background staining
(score 0), weak (score 1) or strong (score 2).
Nuclear staining was reported as present (>10%
of nuclei) or absent. The immunohistochemical
stainings were independently scored by two
pathologists (SB and RL) on a Zeiss Axioskop
microscope at 40x objective magnification.
Interobserver agreement for the evaluation of
dot like LC3B staining had a kappa value of 0.74
using the Cell signaling antibody (substantial
agreement), and 0.60 for the Novus antibody
(moderate to substantial agreement). For the
p62/Sigma antibody the kappa values were as
follows: dot like staining 0.65 (substantial agree-
ment); cytoplasmic staining 0.83 (excellent) and
nuclear 0.75 (substantial). The kappa values for
the MBL antibody were only fair to moderate
(0.3, 0.42 and 0.56, respectively). We selected
the antibodies with the better interobserver
agreements for further studies, presuming
staining results to have a greater potential for
unambiguous and reproducible evaluation. In a
second round, discrepancies were discussed on
a multihead microscope and final scores were
determined. Using this approach for LC3B (Cell
Signaling) dot-like staining, 22 cases (37.3%)
were classified as score 0, 8 cases (13.6%) as
score 1 and 5 cases each (8.5%) as score 2 and
3. The results for p62 (Sigma) were as follows:
score 0, 12 cases (20.3%); score 1, 8 cases
(13.6%); score 2, 4 cases (6.8%) and score 3
(including also the cases with strong cytoplas-
mic staining), 16 cases (27.1%) (Table 1).
Eleven cases were both LC3B and p62 negative,
and 17 cases had detectable dots for both LC3B
and p62 (Fishers exact test = 0.004; Table 2).
There was no association between p62 nuclear
and dot-like/cytoplasmic staining, and no signif-
icant difference between gastric and lung can-
cers with regard to the distribution of staining
patterns.
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Figure 2. Validation of immunohistochemical staining for p62. Autophagy was induced
by starvation in EBSS media, and autophagic flux blocked using the late autophagy
inhibitor Bafilomycin A1. A) p62 western blot analysis of H1299 p62 knockdown
(shp62) compared to control (shCTRL) cells; GAPDH is shown as a loading control;
band quantification was done using ImageJ software. B) Quantification of p62 positive
dots from immunofluorescent staining; quantification was performed as described in
materials and methods; the non-parametric Mann-Whitney-U was used to compare dif-
ferent groups: *P<0.05. C) Immunofluorescent staining (left panel) and immunohisto-
chemistry (right panel) of p62 in H1299 control and p62 depleted cells treated as
described above; for immunofluorescence analysis the p62/Sigma antibody was used, and
nuclei were counterstained using DAPI; two different p62 antibodies (Sigma and MBL)
were used for immunohistochemical staining. Scale bars: 20 µm. 
Table 1. Correlation between LC3B and p62 (c2=0.057).
                                                                LC3B                                        Total
                                                  Score 0            Score 1          Score 2     Score 3              
p62                         Score 0                           11                             1                            0                      0                        12
                               Score 1                            3                              3                            1                      1                         8
                               Score 2                            1                              1                            0                      2                         4
                               Score 3*                          7                              3                            4                      2                        16
                               Total                                22                             8                            5                      5                        40
*Including strong cytoplasmic staining.
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Discussion
The application of LC3B and p62 IHC for
monitoring autophagy has generally been
regarded to represent a possible tool for study-
ing autophagy.18,23,24 However, the appropriate
usage of IHC on tissue has been a topic of dis-
cussion in recent papers, especially in view of
numerous studies, which had been using this
technique without caution.24-26 Consistent with
our observations on cell lines, where
autophagy was experimentally induced,
Martinet et al.17 pointed out that granular cyto-
plasmic staining without detectable puncta or
dots may not truly reflect autophagy. They also
discuss the limitation of IHC for the usage of
monitoring autophagy at basal or low levels,17
reflected in our study by generally lower quan-
tities of dots in tissue compared to starved and
Bafilomycin A1 treated cells. In line with our
results, others have reported LC3B and partly
also p62 positive dot like staining in tissue
samples featuring chloroquine induced myo-
pathic muscle fibers,27,28 hepatic steatosis29 or
various cancer types.30 In the latter paper, a
detailed protocol for IHC is provided that is
comparable to our approach. Similarly, Holt et
al.31 present another protocol for LC3B IHC, but
both groups describe an in-house approach,
which may not be feasible in other laborato-
ries. Our aim was to design a valid staining
protocol and scoring system with special
emphasis on reproducibility and applicability
on scoring large tumor collectives of FFPE tis-
sue. For that reason we took advantage of an
automatic immunostainer routinely used in
pathology laboratories and opted to set specific
thresholds for evaluation of dot-like staining to
assure reproducibility and feasibility evaluat-
ing large tissue collectives. 
We observed similar patterns for both
autophagy markers, LC3B and p62, as recently
described in oral squamous cell carcinomas.32
Yet, it is highly important that distinct LC3B
and p62 staining can also be observed in nor-
mal nerves and macrophages, which can serve
as internal positive controls, but also seriously
confound staining results. Careful histopatho-
logic examination is therefore mandatory to
elude misinterpretation. The observed strong
diffuse cytoplasmic staining for p62 might
hamper evaluation of fine cytoplasmic dots.
The significance of diffuse cytoplasmic and
nuclear p62 staining for assessment of
autophagy is not clear. While others interpret
both staining patterns as surrogates for
autophagy,32 we prefer to restrict autophagy
assessment to dot-like staining patterns, anal-
ogous to LC3B, based on our preceding cell line
experiments. Another critical issue is the
interpretation of the biological significance of
LC3B and p62 positive dots. Dot like staining
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Figure 3. Staining of LC3B and p62 in neoplastic and non-neoplastic lung and gastric
tissue. A-C) Non-neoplastic lung tissue: hematoxylin and eosin stain (A); cytoplasmic
and dot-like staining of macrophages and bronchial epithelium for LC3B/Cell signaling
(B) and p62/Sigma (40x) (C). D-F) Non-neoplastic gastric tissue: nuclear staining of
p62/Sigma in the foveolar mucous neck region (D) and accentuated in inflamed tissue
(F). E) additional staining of zymogen granula by p62/MBL (10x). G-I) LC3B positivity
of nerve tissue (arrow), adjacent to a negative gastric cancer infiltrate: hematoxylin and
eosin (G); LC3B/Cell Signaling (H); LC3B/Novus (40x) (I). Dot like staining of lung car-
cinoma for LC3B/Cell Signaling (J), LC3B/Novus (K), p62/MBL (L) and p62/Sigma
(100x) (M). Inserts show magnification of positive cells (score 3 according to Table 1).
Images were taken on a Zeiss Axioskop microscope and corrected for brightness.
Objective magnifications are reported. Scale bars: 100 µm.
Table 2. Correlation of the presence of dots with LC3B and p62 staining (Fisher’s exact
test = 0.004). 
                                                                                  LC3B dots                                 Total
                                                        Absent (score 0)       Present  (score 1-3)
P62 dots       Absent (score 0)                                    11                                               1                                12
                      Present (score 1-3*)                             11                                              17                               28
                      Total                                                           22                                              18                               40
*Including strong cytoplasmic staining.
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patterns do not necessarily indicate high levels
of active, ongoing autophagy. Autopha -
gosomes, visualized as dots, may accumulate
due to induction of autophagy itself, or due to
inhibition of autophagy and the resulting lack
of autophagosome degradation upon fusion
with lysosomes.31 Thus, autophagosome accu-
mulation due to a defective autophagy pathway
may account for some positive cases and would
warrant the application of additional markers
in order to achieve a more comprehensive
dataset of the expression of autophagy related
biomarkers. In fact, although there was a posi-
tive correlation between LC3B and p62 stain-
ing, some cases showed single positivity for
LC3B or p62. LC3B can be incorporated into
protein aggregates independently of functional
autophagy under certain stress stimuli.8 Thus,
some LC3B positive structures might not
reflect autophagosomes. Accordingly, although
p62 is a well-known autophagy cargo, the lev-
els of p62 are controlled transcriptionally by
various non-autophagic stimuli that may lead
to a misinterpretation of autophagic flux.3 On
the other hand, our functional autophagy
experiments in cancer cells strongly support
the relation between autophagy and dot like
staining of the two markers. Specificity of anti-
bodies should always be taken into account.
IHC staining patterns using two commercially
available LC3B antibodies were highly compa-
rable in our cell lines. Of note though, LC3B
antibody from Cell Signaling is specific for
LC3B,17 whereas the antibody purchased from
Novus Biologicals cross-reacts with LC3A.22
At present, data about the expression of
other human ATG8 homologues, i.e.,
GATE16/GABARAP in human tissue are scarce.
Only one study has addressed the expression
of GABARAP in colon cancer.33 Data from the
human protein atlas  (http://www.proteinat-
las.org/)34 show expression of GABARAP1 and
GAPARAP2/GATE16 in samples of neoplastic
and non-neoplastic human tissue in various
levels. Descriptive or comparative studies
about these proteins on larger case collections,
however, are lacking. Therefore, despite all
caveats and problematic issues, staining for
LC3B and p62 may be the best way to assess
differences in the autophagy pathway in large
human tissue collectives, where electron
microscopy is not feasible, as long as we lack
other more precise markers to monitor
autophagic flux in tissue. Combining function-
al cell line experiments and IHC on tissue will
provide further insights into the deregulation
of autophagy in pathological conditions. 
In summary, we developed a specific and
reliable LC3B and p62 IHC staining protocol for
human FFPE tissue, which can be applied on
an automatic staining system widely available
in pathology laboratories. Preceding functional
cell line experiments with LC3B and p62
knockdown and subsequent induction of
autophagy followed by Western blot, immuno-
fluorescence and immunohistochemistry
analyses of the cell pellets indicate that only
dot-like staining patterns should be regarded
as autophagy-related. The specificity of the
antibodies for LC3B and p62 was tested by
Western blot as a prerequisite for a reliable
immunohistochemical staining protocol.35 The
reproducibility of the staining and the pro-
posed evaluation system were confirmed by a
high degree of interobserver accordance
between two pathologists. Application of IHC
staining was performed on a tissue microarray
with human malignant and non-neoplastic
lung and stomach tissue samples. Distinct dot
like staining patterns for LC3B and p62 were
observed within the tumors in various degrees,
but in general in higher levels compared to the
corresponding non-neoplastic tissue. Applying
LC3B and p62 IHC on single tissue samples
and tissue collections may be a valuable tool
for determining the impact of autophagy on
human diseases where tissue based analyses
are demanded.
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